Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab.

ABSTRACT:

Background

Personal treatment goals have been systematically investigated in psoriasis patients with active but not in controlled disease.

Objectives

To explore patient needs in psoriasis patients with controlled disease due to biologic therapy with adalimumab, etanercept or ustekinumab.

Methods

Treatment needs in patients on adalimumab, etanercept or ustekinumab with a stable low disease activity for ≥ 6 months and preferably a Psoriasis Area and Severity Index (PASI) < 5, were explored with the Patient Needs Questionnaire (PNQ). Goal importance was expressed as overall mean importance score, percentage of patients that reported a goal to be quite/very important, and per PNQ subscale. Data were analysed separately for treatment, gender, age group (< 50 vs. ≥ 50 years

SUBMITTER: van Muijen ME 

PROVIDER: S-EPMC8128951 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature